Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy
about
Ubc13: the Lys63 ubiquitin chain building machineBacteria in Cancer Therapy: Renaissance of an Old ConceptCancer Metabolism and Drug ResistanceCancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer controlAnti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrenceGold nanoparticles for cancer radiotherapy: a reviewThe Repurposing Drugs in Oncology (ReDO) Project.Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma modelA metal-containing nucleoside that possesses both therapeutic and diagnostic activity against cancerCovalent Inhibition of Ubc13 Affects Ubiquitin Signaling and Reveals Active Site Elements Important for Targeting.Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma.Regulation of MAPKs Signaling Contributes to the Growth Inhibition of 1,7-Dihydroxy-3,4-dimethoxyxanthone on Multidrug Resistance A549/Taxol Cells.Diterpenoid C of Radix Curcumae: an inhibitor of proliferation and inducer of apoptosis in human colon adenocarcinoma cells acting via inhibiting MAPK signaling pathway.High cofilin-1 levels correlate with cisplatin resistance in lung adenocarcinomas.Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome.Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug.Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies.Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide.Aggregation Effects and Population-Based Dynamics as a Source of Therapy Resistance in Cancer.[Bone metastases : New aspects of pathogenesis and systemic therapy].Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells
P2860
Q26739716-35B96226-F42B-4951-8E66-0C63F32FFB69Q26751222-973D6E2A-0D7C-4AFA-85B7-50D1C39A35A6Q26782042-F39F82E8-01E4-492F-AB61-FDE2C81BEAC5Q26860058-210756A7-D085-4129-B97F-C5E60D8EAF7AQ27010314-2BE6A5F3-5760-44D7-B7E6-05B6899C88B6Q28066413-B2F861D8-2D5A-41E3-B04C-D0F49A580CD3Q33893949-94551B2D-55D1-4BE0-8765-C5FFA4F01C78Q34173568-16548424-950C-4480-9B6D-B4002E3F228BQ35351955-E725F32F-C8D5-4C58-BB9B-DA3D08CAC4DAQ35864085-47904A2B-7A95-4709-B1BE-52BF835D1E8AQ38724921-F09CDCAB-4273-4B17-A12C-E41A2225F873Q38758665-0A51FE4C-EE71-4949-8331-BFA4D08A3F7BQ39013941-7708EA75-5782-4ECC-9181-54F8EB34EC73Q39098144-A69D9B00-8087-491C-8022-5624D6439143Q40108146-AC3D3D23-6472-434A-930B-D873A5A0ED1AQ43376055-EB853F67-1443-47FB-A535-6E70144D049FQ47554623-5ECADD9C-DF3E-4A32-98BA-37F912996CA8Q48344360-F9B07510-8A1A-41A1-BA5E-0E75ADF85F31Q52922032-7E8340CE-1154-406E-83B7-B81CAD179022Q53062244-2CE3CA34-C4C1-491D-B546-99100F26E024Q58889406-FC835A01-C467-411E-B4A5-57B81948AE56
P2860
Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Is it time for a new paradigm ...... century of cancer chemotherapy
@en
type
label
Is it time for a new paradigm ...... century of cancer chemotherapy
@en
prefLabel
Is it time for a new paradigm ...... century of cancer chemotherapy
@en
P2860
P356
P1476
Is it time for a new paradigm ...... century of cancer chemotherapy
@en
P2093
Sarah Crawford
P2860
P356
10.3389/FPHAR.2013.00068
P577
2013-06-25T00:00:00Z